For citations:

Matveev V.B., Chernyaev V.A. Sorafenib is the first targeted agent to treat metastatic kidney cancer. Cancer Urology. 2015;11(1):73-78. (In Russ.) https://doi.org/10.17650/1726-9776-2015-1-73-78